# OBX (Obsidian Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Obsidian Therapeutics, Inc. reported $340.7M in total assets through September 30, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/OBX
- Markdown: https://convexityos.com/fundamentals/OBX.md
- SEC CIK: 0002130606
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:05 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002130606&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Sep 30, 2026 |
| Operating Income | FY 2026 | -- | Operating profit |
| Net Income | FY 2026 | -- | GAAP bottom line |
| Diluted EPS | FY 2026 | -- | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $214.9M | Total debt: $4.05M |

## Income Statement

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | -- | -- | $0 | -- | -- |
| Research & Development | $27.55M | -- | -- | $25.05M | -- | -- |
| Total Operating Expenses | $52.91M | -- | -- | $29.63M | -- | -- |
| **Operating Income** | -$52.91M | -- | -- | -$29.63M | -- | -- |
| Income Before Tax | -$50.66M | -- | -- | -$28.47M | -- | -- |
| Income Tax Expense | $0 | -- | -- | $0 | -- | -- |
| **Net Income** | -$50.66M | -$25.86M | -$19.63M | -$28.47M | -$26.90M | -$24.99M |
| Basic EPS | -$1.23 | -- | -- | -$14.77 | -- | -- |
| **Diluted EPS** | -$1.23 | -- | -- | -$14.77 | -- | -- |
| Basic Shares Outstanding | 41.0M | -- | -- | 1.9M | -- | -- |
| Diluted Shares Outstanding | 41.0M | -- | -- | 1.9M | -- | -- |

## Balance Sheet

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Dec 2025 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $66.51M | -- | $40.41M |
| Short-Term Investments | $148.4M | -- | $40.08M |
| **Cash & Short-Term Investments** | $324.4M | -- | $80.50M |
| **Total Current Assets** | $224.5M | $0 | $81.52M |
| Property, Plant & Equipment, Net | $961K | -- | $1.91M |
| Long-Term Investments | $109.4M | -- | $0 |
| Other Non-Current Assets | -- | $0 | -- |
| **Total Non-Current Assets** | $116.2M | $0 | $7.06M |
| **Total Assets** | $340.7M | $0 | $88.58M |
| Accounts Payable | $569K | -- | $12K |
| Other Current Liabilities | $1.59M | -- | $1.42M |
| **Total Current Liabilities** | $18.26M | $0 | $15.36M |
| Other Non-Current Liabilities | $0 | $0 | $3.0K |
| **Total Non-Current Liabilities** | $1.90M | $299.7M | $1.23M |
| **Total Liabilities** | $20.16M | $299.7M | $16.59M |
| **Total Debt (incl. Leases)** | $4.05M | -- | $4.28M |
| Common Stock | $6.0K | $0 | $1.0K |
| Retained Earnings | -$392.1M | $0 | -$295.9M |
| Accumulated Other Comp. Income | -$1.20M | $0 | $23K |
| **Total Stockholders' Equity** | $320.6M | -$299.7M | -$266.0M |
| Total Equity | $320.6M | -$299.7M | -$266.0M |

## Cash Flow Statement

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | $50.66M | -$25.86M | -$19.63M | $28.47M | -$26.90M | -$24.99M |
| Stock-Based Compensation | $2.26M | -- | -- | $2.23M | -- | -- |
| Change in Working Capital | -- | $0 | -- | -- | -- | -- |
| **Operating Cash Flow** | -- | $0 | -- | -- | -- | -- |
| **Investing Cash Flow** | -- | $0 | -- | -- | -- | -- |
| **Financing Cash Flow** | -- | $0 | -- | -- | -- | -- |
| **Net Change in Cash** | -- | $0 | -- | -- | -- | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Current Ratio | 12.29x | -- | -- | -- | -- | -- |
| Quick Ratio | 17.76x | -- | -- | -- | -- | -- |
| Debt to Equity | 0.01x | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
